Clinical Trials Directory

Trials / Conditions / Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

11 registered clinical trials studyying Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Respon
NCT07408063
University Health Network, TorontoPhase 2
Not Yet RecruitingA Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line an
NCT07354984
Sun Yat-sen UniversityPhase 2
RecruitingIparomlimab and Tuvonralimab in HNSCC
NCT07090317
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2
RecruitingSacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
NCT07088211
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2
RecruitingA Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead a
NCT07059221
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1 / Phase 2
RecruitingStudy of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5F
NCT06856213
Grupo Español de Tratamiento de Tumores de Cabeza y CuelloPhase 2
RecruitingDalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
NCT06935188
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2
UnknownCetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC
NCT05721443
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2
RecruitingA Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastat
NCT05286619
University of MalayaPhase 2
UnknownSintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC.
NCT04882462
The First Affiliated Hospital of Soochow UniversityPhase 2
CompletedStudy to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and
NCT04282109
Grupo Español de Tratamiento de Tumores de Cabeza y CuelloPhase 2